Actionable news
All posts from Actionable news
Actionable news in SGMO: Sangamo BioSciences, Inc.,

Sangamo Biosciences' (SGMO) CEO Edward Lanphier Discusses Q3 2015 Results - Earnings Call Transcript


Good afternoon and welcome to the Sangamo BioSciences teleconference to discuss Third Quarter 2015 Financial Results. This call is being recorded. I will now pass you over to the coordinator of this event, Dr. Elizabeth Wolffe, Vice President of Corporate Communications.

Elizabeth Wolffe - Vice President, Corporate Communications

Thank you, Brian. Good afternoon and thank you for joining Sangamo’s management team on our conference call to discuss the company’s third quarter 2015 financial results.

Also present during this call are several members of Sangamo’s senior management, including Edward Lanphier, President and Chief Executive Officer; Ward Wolff, Executive Vice President and Chief Financial Officer; Geoff Nichol, Executive Vice President of Research and Development; Dale Ando, Vice President of Therapeutic Development and Chief Medical Officer; Mike Holmes, Vice President of Research and Fyodor Urnov, Senior Scientist and Head of Hemoglobinopathies Program.

Following this introduction, Edward will highlight recent activities and the significant events from the past quarter...